Market Cap (In CNY)
650.31 Million
Revenue (In CNY)
87.26 Million
Net Income (In CNY)
-20.03 Million
Avg. Volume
6.4 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.28-15.97
- PE
- -
- EPS
- -
- Beta Value
- 0.139
- ISIN
- CNE100002VL4
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Jun Xiang Yang
- Employee Count
- -
- Website
- https://www.daliyaoye.cn
- Ipo Date
- 2017-09-22
- Details
- Dali Pharmaceuticalco.,Ltd researches, develops, produces, and sells pharmaceutical products in China. It develops Chinese and Western medicine injection products of 20 varieties with 44 specifications of the injection drug approval number. The company's products include xingnaojing, shenmai, and astragalus injections, as well as leucocin A and citicoline injections. It also has 31 patents, including 11 invention patents, 16 utility models, and 3 design patents. The company was founded in 1996 and is headquartered in Dali, China.
More Stocks
-
SHRICONShricon Industries Limited
SHRICON
-
ORGN
-
002019
-
DSV
-
NIKHILADNikhil Adhesives Limited
NIKHILAD
-
300486OMH SCIENCE Group Co., Ltd
300486
-
DNA
-
EGS745W1C011Al Moasher for Programming and
EGS745W1C011